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Although Ia or Class II major histocompatibility antigens have generally been 
associated with  cells of the  immune  system, recent  studies  have demonstrated 
the presence of Ia antigens on cells with no known immune functions (1-8). One 
of these cell types is malignant  melanoma (1,  3).  While Ia can be demonstrated 
on a  proportion  of both cultured and  noncultured  specimens of melanoma (9, 
10),  no |a antigens  have been detected on normal  melanocytes, either in vitro 
(9) or in vivo (10). A possible explanation  for this finding is that Ia antigens are 
expressed on an early, as yet unidentified cell in the normal  melanocyte lineage 
and  that  Ia + melanomas  arise  from  this  Ia ÷ progenitor  (9).  According  to  this 
view, Ia antigens would be classified as differentiation antigens in the melanocyte 
pathway, defined as such  because they are expressed during  an early stage of 
normal melanocyte differentiation.  An alternative view is that the expression of 
Ia antigens on melanomas is a consequence of events occurring during malignant 
transformation  (3,  9).  As  a  corollary  to  this  view,  Ia  antigens  would  not  be 
expressed during normal melanocyte differentiation. 
A number of reports have demonstrated that y-interferon (IFN-3,) ~ can induce 
or augment the expression of Ia antigens on several different cell types, including 
melanoma  (1 1,  12).  To  pursue  this  observation  with  regard  to  normal  and 
transformed cells belonging to the melanocyte series, we have asked the following 
questions: (a) Is induced/augmented expression of Ia antigens by IFN-~/a general 
feature of melanomas or is it a characteristic of only a subset of melanomas? (b) 
Can normal melanocytes be induced to express Ia? (c) How specific is Ia induction 
by IFN-3,:  what  is  the  activity  of other  species of interferon  or other  factors 
known  to  influence  growth  or  differentiation?  (d)  Is  Ia  induction  part  of a 
coordinate  change  in  the  program  of cell  surface  differentiation  antigens  ex- 
pressed by melanomas  or is  it  restricted  to surface antigens  coded for by the 
major histocompatibility complex, and finally, (e) how broad is the range of cell 
types that can be induced to express Ia by IFN-3,? 
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Materials and Methods 
Cell Lines.  Melanocytes and keratinocytes were cultured as previously described (13, 
14). The melanocyte-3 cell line was kindly provided by Dr. M. Eisinger, Sloan-Kettering 
Institute. Other cell lines were obtained from our cell bank. Cell lines were cultured in 
Eagle's Minimum  Essential  Medium (MEM),  2  mM  glutamine,  1%  nonessential amino 
acids,  100 U/ml penicillin, and  100 ug/ml streptomycin (MEM  medium) supplemented 
with 7.5% fetal bovine serum (FBS). Cultures were regularly tested for mycoplasma and 
contaminated cultures were discarded. 
Sources of Human IFN and Other Agents.  Recombinant IFN-3, was provided by Genen- 
tech,  Inc. (S. San  Francisco, CA) and natural  IFN-y by Interferon Sciences, Inc. (New 
Brunswick, NJ). The activity of IFN-3~ preparations, determined in NIH units by Dr. B. 
Rubin, Sloan-Kettering Institute, was 1 x  105 U/ml for natural IFN-3, and 2 x  10  4 U/ml 
for recombinant IFN-3'.  Natural IFN-B 1.5 ×  106 U/ml was obtained from Roswell  Park 
Memorial Institute (Buffalo, NY), natural leukocyte IFN-c~ (Le) 3.3 X 106 U/ml from the 
New York Blood Center (New York, NY), natural lymphoblastoid IFN-a (Ly) 5.4 ×  106 
U/ml from the Wellcome Foundation (London, Great-Britain), and recombinant IFN-a 
3.4  x  106  U/ml  from Hoffmann-LaRoche (Nutley, NJ).  Other agents came from the 
following sources: endotoxin (Novo Pyrexal), HermaI-Chemie Kurt Hermann (Hamburg, 
Federal Republic of Germany); phorbol 12-myristate-13-acetate (PMA), P-L Biochemicals 
(Div. of Pharmacia, Inc., Piscataway, N  J); cholera toxin, Schwarz-Mann (Div. of Becton, 
Dickinson  and  Co.);  retinoic acid,  dibutryl  cAMP,  theophylline,  5-azacytidine,  Sigma 
Chemical Co. (St. Louis, MO); human T cell growth factor (TCGF), glycyl-histidyl-lysine, 
nerve growth factor, Collaborative Research, Inc. (Waltham, MA). Mouse tumor necrosis 
factor (15) was provided as a partially purified preparation (20,000 U/mg) by E. Carswell, 
Sloan-Kettering Institute. 
Serological Reagents.  The following mouse monoclonal antibodies were used for ser- 
ological testing: 
Monoclonal anti-  Antigenic determinant  Source of antibody or hybri- 
body  doma (reference) 
L243  Ia monomorphic  American Type Culture Collec- 
tion (ATCC), Rockville, MD 
(16) 
S-1-71  Ia monomorphic  M. Tanimoto, Sloan-Kettering 
Institute, New York, NY 
13-17  Ia monomorphic  (17, 18) 
MCS-7  DR3,5,w6  N. Tanigaki, Roswell Park 
Memorial Institute, Buffalo, 
NY (19) 
BT 3/4  DC-1  G. Corte, Instituto di Chimira 
Biologica, Genova, Italy (20) 
Genex 3.53  DC-1  ATCC (21) 
W6/32  HLA-A,B,C  ATCC (22) 
BBM. 1  /3~m  ATCC (23) 
M-1 through M-9, 
M-13,  M-14, M- 
18, M-19, M- 
28, M-32, M-34 
Melanoma/melanocyte cell sur- 
face antigens 
(see reference 9) HOUGHTON  ET  AL.  257 
T87, T43,J143, 
V1, AJ9, AJI7, 
AJ425, L101, 
M368, M138, 
A123, L2-30 
$4,$22,$25, 
T138, OM5, 
J233,JP165, 
F3, F15, F18 
Cell surface antigens expressed 
by most human cell types, in- 
cluding melanomas and mela- 
nocytes 
Cell surface antigens expressed 
by epithelial cell types, but 
not by melanomas or melano- 
cytes 
Human Cancer Serology Labo- 
ratory, Sloan-Kettering Insti- 
tute, New York, NY 
Human Cancer Serology Labo- 
ratory, Sloan-Kettering Insti- 
tute, New York, NY 
Human typing serum Hon (BR4 Class II MHC antigen) has been described previously 
(24), and the reactivity of natural antibody detecting the Mel-1 differentiation antigen of 
melanomas and melanocytes (M-10) has been reported (25). 
Serological Assays.  The anti-mouse  immunoglobulin (anti-mouse  Ig) and  protein  A 
(PA) mixed hemadsorption assays were performed as previously described (26, 27). To 
prepare indicator cells, anti-mouse Ig (Accurate Chemical and Scientific Corp., Westbury, 
NY) or PA (Pharmacia Fine Chemicals, Div. of Pharmacia, Inc.) was conjugated to type 0 
human erythrocytes using 0.01% chromium chloride. Serological assays were performed 
on cells previously plated in Falcon 3034 plates. Antibodies were incubated with target 
cells at 20°C for 1 h. Target cells were then washed and indicator cells added for 1 h. 
Titers were defined as the antibody dilution showing 50% positive (rosetted) target cells 
(26). 
Induction Assays.  Assays for antigen induction were performed in Falcon 3034 plates 
(Falcon Labware, Div.  of Becton, Dickinson and Co.,  Oxnard, CA).  Target cells  were 
plated at 200 cells/well in MEM medium plus 7.5% FBS. 2-4 h after plating, the agent 
to  be  tested  was  added  to  the  medium  in  each  well  to  give  the  appropriate  final 
concentration. Cells were then cultured at 37°C in 5% CO2 and serological assays were 
performed at indicated intervals. 
Metabolic Labeling and Biochemical Identification of la Antigens.  Cells were labeled with 
[35S]methionine and the cell extracts were fractionated on a concanavalin A-Sepharose 
column  (Pharmacia,  Inc.)  and  eluted  with  0.2  M  methyl-a-o-mannoside (18).  Eluted 
extracts were immunoprecipitated (18) and analyzed by sodium dodecyi sulfate-polyac- 
rylamide gel electrophoresis (SDS-PAGE). 
Results 
Induced/Augmented  Expression  of la Antigens  by IFN-'~ Is a  General Feature of 
Melanoma.  A  series  of melanoma  cell  lines  were  tested  for expression  of Ia 
antigens before and after exposure to natural IFN-3, or recombinant IFN-3,. Fig. 
1 illustrates  the response of SK-MEL-113, a  melanoma  cell line that  shows  no 
expression of Ia under normal growth conditions but can be induced to express 
high levels of Ia after growth in natural or recombinant IFN-3,. Fig. 2 summarizes 
tests  with  a  panel  of  36  melanoma  cell  lines.  In  the  absence  of  IFN-3',  20 
melanoma  cell lines  express  Ia  in a  constitutive fashion  and  16  express no  Ia. 
Melanomas with constitutive Ia expression respond to IFN-3, by augmented (e.g., 
SK-MEL-130), or by little or no change in,  Ia expression. In the case of the  16 
melanoma cell lines that were non-la expressors, 13 could be induced to express 
Ia  by  IFN-~,  and  three  remained  Ia-.  Induced/augmented  expression  of  Ia 
antigens  by IFN-3,  was not associated  with  any changes  in  cell morphology or 
pigmentation. 
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FIGURE  1.  Expression of Ia antigens by SK-MEL-113 melanoma cell line after IFN-'y induc- 
tion. Cells cultured without IFN-'¢, O; cells cultured with recombinant IFN-'y 100  U/ml for 3 
d, ~; cells cultured with purified natural  IFN-'y 200 U/ml for 3 d, 0. Serological assay:  anti- 
mouse Ig mixed hemadsorption assay with L243 antibody. 
could be detected by antibodies directed to monomorphic as well as alloantigenic 
specificities. Fig. 3 shows tests with two Ia- melanoma cell lines, SK-MEL-30 and 
SK-MEL-113,  that  express  Ia  after  IFN-3'  induction.  Both  monomorphic  and 
alloantigenic Ia determinants were demonstrable. 
Induction of Ia expression was related to both the concentration of IFN-3, and 
the  duration  of  exposure.  Preparations  of  natural  IFN-3,  and  recombinant 
IFN-3, showed similar inducing activities and were able to induce Ia antigens on 
melanomas at concentrations as low as 2  U/ml (Fig.  4).  Maximum induction  of 
Ia  occurred  by 3-5  d.  When  IFN-3'  was  removed  from  the  culture  medium, 
expression of Ia antigens  on SK-MEL-113 cells fell and was undetectable  10 d 
later (Fig. 5). To demonstrate that this reversal of Ia antigen expression was not 
due to outgrowth of a  subpopulation of cells resistant  to induction,  melanoma 
cells were re-exposed to IFN-3,.  Upon reinduction,  100%  of cells expressed Ia 
antigens.  Thus,  expression  of  la  antigens  did  not  become  constitutive  after 
induction,  but rather  was reversible and dependent on the continued presence 
of IFN-3,. 
Melanocytes Are  Induced  to  Express  Ia  Antigens  by  IFN-'y.  In  our  previous 
studies, we were unable to detect Ia antigens on cultured melanocytes (9). Fig. 6 
shows that exposure of melanocytes to IFN-w results in high levels of Ia expres- 
sion.  Ia  expression  was detected by three  monoclonal  antibodies  to  Ia  mono- 
morphic  determinants;  in  addition,  DR and  DC-1  determinants  could  be de- 
tected. As observed with melanoma cultures,  Ia expression by melanocytes was 
reversible after induction. 
IFN-~, IFN-t3 and Other Agents Influencing  Growth and Differentiation  Do Not 
Induce  Melanomas  and Melanocytes to  Express Ia Antigens.  A  series  of agents 
including IFN-a and IFN43 were tested for their ability to induce expression of 
Ia antigens on melanoma cell lines and cultured melanocytes (Table I). Natural 
IFN-a, recombinant IFN-o~, and natural  IFN-fl did not induce Ia antigens, even 
up  to concentrations  of 50,000  U/ml.  Both  IFN-ot and  IFN-13 were found  to 
increase the expression of HLA,A,B,C and 132m, and IFN-~ also had this activity 
(see below). Conditioned media from PHA-stimulated peripheral blood lympho- SK-MEL-  15 
SK-MEL-  19 
SK-MEL- 21 
SK-MEL-  25 
SK-MEL- 26 
SK- MEL- 27 
SK-MEL-  28 
SK-MEL- 29 
SK-MEL- 50 
SK- MEL- 51 
SK- MEL- 55 
SK-MEL- 57 
SK- MEL- 41 
SK- MEL- 61 
SK- MEL- 64 
SK- MEL-  75 
SK- MEL- 90 
SK-MEL-94 
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FIGURE 2.  Ia phenotype of melanoma cell IFN-3, induction. Cells cultured without  IFN-3,, 
D; cells cultured with natural IFN-7 200 U/ml for 3 d, lB. Length of horizontal bars represent 
antibody titers:  0,  <1/50;  1+,  1/50--1/1,000; 2+,  >1/1,000-1/10,000;  3+,  >1/10,000. 
Serological assay: anti-mouse Ig mixed bemadsorption assay with L243 antibody. 
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cytes and from mixed lymphocyte cultures were also found to induce Ia antigens, 
most likely due to the presence of IFN-3,  (Table I).  A  variety of other agents 
including TCGF,  endotoxin,  PMA, cholera toxin,  retinoic acid,  nerve growth 
factor, 5-azacytidine, tumor necrosis factor, and conditioned media of Ia  + mela- 
nomas did not affect Ia expression. 
IFN-'y Does Not Induce or Augment the Expression of Non-HLA-related Antigens 
on Melanomas and Melanocytes.  In contrast to the induced/augmented expres- 
sion of Ia and HLA,A,B,C antigens, a wide range of other cell surface antigens 
expressed by melanomas, melanocytes, or other cell types was not influenced by 
IFN-'y. In these tests, antibodies detecting the following antigenic systems were 
used (see Materials and  Methods):  (a)  16  melanocyte differentiation antigens, 
including antigens expressed during early (antigens M- 1, M-2, M-3), intermediate 
(antigens  M-4,  M-5,  M-6)  or  late  (antigens  M-9,  M-10)  stages  of melanocyte 
differentiation (Table II); (b)  10 widely distributed antigens that are expressed 
by most human cell types, and (c) 12 antigens that are not found on melanomas 260  SPECIFICITY OF  Ia  ANTIGEN  INDUCTION  BY  3,-INTERFERON 
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FIGURE 3.  Expression of la, monomorphic and Ia alloantigenic determinants on melanoma 
cells after  IFN-3, induction. (a)  SK-MEL-30 melanoma cells tested  with  antibodies to  Ia 
monomorphic determinants (L243,  13-17, S-1-71); (b) SK-MEL-113 melanoma cells tested 
with antibodies to la alloantigenic  determinants; MCS-7 (anti-DR-3,5,w6), BT 3/4 (anti-DC-1) 
and Hon (anti-BR4X7). Cells cultured without IFN-% O; cells cultured with purified natural 
IFN-3" 200 U/ml for 3 d, 0. Serological assay: anti-mouse Ig mixed hemadsorption with L243, 
13-17, S-1-71, MCS-7 and BT 3/4 antibodies and protein A assay with antibody Hon. 
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FIGURE 4.  Expression  of la antigens by SK-MEL-113 cells after induction with different 
concentrations  of IFN-3,. Cells cultured with recombinant IFN-3" for 3 d, @; cells cultured with 
purified natural IFN-3, for 3 d, O. Serological assay: anti-mouse Ig mixed hemadsorption assay 
with L243 antibody (diluted  1:5,000). 
or  melanocytes,  but  are  expressed  by epithelial  cell  types (e.g.,  lung  cancer, 
bladder cancer,  and  colon cancer).  These  tests show the  striking  specificity of 
IFN-3, for products of the HLA (and/32m) loci. 
A Broad Range of Cell Types Can Be Induced to Express la Antigens by IFN-~/.  To 
determine the range of cell types that can be induced to express Ia by IFN-3,, a 
panel of human cancer cell lines and cultured normal cells representing a number 
of distinct differentiation  lineages were selected for study (Fig.  7).  Constitutive 
expression of Ia was frequent in astrocytoma cell lines (7/19  Ia+).  However, in 
contrast to melanoma and astrocytoma, constitutive Ia expression was an uncom- 
mon phenotype of epithelial cell types, teratocarinomas,  choriocarcinomas,  and ~10C 
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FIGURE 5.  Expression of la antigens by SK-MEL-113 cells after IFN-3, induction: effect of 
IFN-3' removal and reinduction with IFN-~(. Cells were cultured in the presence of purified 
natural IFN-7 200 U/ml for 8 d. IFN-3, was removed on day eight and re-added on day 21. 
Serological assay:  anti-mouse Ig mixed  hemadsorption assay  with  L243 antibody (diluted 
1:5,000). 
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FIGURE 6.  Expression of Ia antigens by melanocytes after induction with purified natural 
IFN-3' 200  U/ml for 3 days. Melanocytes-1 uninduced (O) and induced (O); melanocytes-2 
uninduced (f-I) and induced (I); melanocytes-3 uninduced (ZX) and induced (&). Serological 
assay: anti-mouse Ig mixed hemadsorption assay with L243 antibody. 
neuroblastomas.  Many of the epithelial cell lines could be induced to express Ia 
by IFN-7. Teratocarcinoma,  choriocarcinoma,  and neuroblastoma were excep- 
tions in this regard; only 1 of 16 cell lines derived from these tumor types showed 
weak Ia expression after exposure to IFN-% 
Induction  of Ia  antigens  was confirmed  by immunoprecipitation  analysis of 
metabolically labeled cells. In the example shown in Fig. 8, both heavy and light 
chains of the Ia molecule were detected in extracts of the melanoma cell line SK- 
MEL-11:3 and the colon cancer cell line HT-29 after induction with IFN-7, but 
not  after  induction  with  IFN-o~. No  Ia  antigen  was  detected  in  extracts  of 
choriocarcinoma cell line GCC-SV(C) before or after IFN-y induction. 
Parallel  tests for expression of HLA-A,B,C products and  132m indicated that 
IFN-3,  could  induce  the  expression  of these  antigens  in  cell  types  that  were 
noninducible for Ia expression. Fig. 9 illustrates the responses of three cell types 
to  IFN-'r  with  regard  to  Ia  and  HLA-A,B,C  expression.  SK-MEL-37  has  a 
constitutive Ia+/HLA-A,B,C + phenotype that  is not altered by IFN-%  Melano- 262  SPECIFICITY  OF  Ia  ANTIGEN  INDUCTION  BY  y-INTERFERON 
TABLE  I 
Assays for Induction of la Antigen Expression: Summary of Results with 
Melanoma SK-MEL-113 and Melanocytes 
Ia 
Agent  Concentrations tested  induction 
IFN-y, natural  0.5 U/ml-5 x  104 U/ml  + 
IFN-y, recombinant  0.5 U/ml-5 x  104 U/ml  + 
IFN-13, natural  50 U/ml-5 x  104 U/ml  - 
IFN-a, Le  50  U/ml-5 X  104 U/ml  - 
1FN-c~, Ly  50 U/ml-5 x  104 U/ml  - 
IFN-a, recombinant  50 U/ml-5 x  104 U/ml  - 
Endotoxin  10 -s g/ml- 10 -~° g/ml  - 
PMA  10 -s g/ml-10  -l° g/ml  - 
Cholera toxin  10  -s M-10 -~° M  - 
Retinoic acid  10 -5 M-10 -s M  - 
Nerve growth factor  10 -7 g/ml-10  -9 g/ml  - 
Dibutryl cAMP  10 -~ M-10 -4 M  - 
Theophylline  10  -3 M-10 -4 M  - 
5-Azacytidine  5 x  10 -7 M-5 x  10 -s M  - 
Glycyl-histidyMysine  10 -8 g/ml- 10 -7 g/ml  - 
Mouse tumor necrosis factor  1 ttg/ml-30 #g/ml 
Human TCGF  5-20 half-max. U/ml  - 
Phytohemagglutinin  5 #g/ml  - 
Conditioned medium from: 
Ia  + melanomas  V~ dil-lk0 dil  - 
PHA-stimulated PBL  IA dil-lAo dil  + 
Mixed lymphocyte reactions  V2 dilJAo dil  + 
Cells were cultured for 5  d  with a  range of concentrations of inducing agents 
and tested for la antigen expression in the anti-mouse Ig mixed hemadsorption 
assay using L243 antibody. 
cytes have an Ia-/HLA-A,B,C + phenotype before IFN-y induction, and convert 
to Ia + after induction (with little or no change in HLA-A,B,C expression). Tera- 
2 lacks demonstrable  Ia or HLA-A,B,C expression when grown in the absence 
of IFN-y.  IFN-y induces  HLA-A,B,C expression  in Tera-2  cells, but does not 
induce Ia expression. Three other teratocarcinomas (Tera-1,577M,  833K), five 
neuroblastomas (LA-N-In,  SH-EP-15, SMS-KAN, SMS-MSNb, SMS-SAN), and 
one choriocarcinoma [GCC-SV(C)] have also shown this dissociation between Ia 
and HLA-A,B,C induction by IFN-% 
Discussion 
Established  melanoma  cell  lines  show  wide  variation  in  Ia expression,  from 
lines with  uniformly strong Ia expression  to those that show no Ia expression. 
Melanomas with constitutive expression of Ia respond to IFN-'y with augmented 
or with little or no increase in Ia expression, whereas non-Ia expressors fall into 
two  groups  on  the  basis  of  Ia  induction  by  IFN-7:  inducible  (13  lines)  or 
noninducible (3 lines).  IFN-y has remarkable specificity with regard to its effect 
on Ia expression by melanoma; IFN-~ and IFN-15 do not have this action and 12 
other agents with growth/regulatory  activity for cells were also without effect. 
Equally striking is the fact that the inducing effect of IFN-3, was restricted to Ia HOUGHTON  ET  AL. 
TABLE II 
Influence of lFN-7 on the Cell Surface Phenotype of Melanoma SK-MEL-113 and 
Melanocytes: Summary of Results with Monoclonal Antibodies Detecting 19 
Different Surface Antigen Systems 
263 
Cell surface 
antigen 
SK-M  EL- 113  Melanocyte- 1 
Titer  Titer  Titer  Titer 
-IFN-7  + IFN-3,*  -IFN-3'  + IFN-),* 
Ia  --  5X 10  -~  --  2× 10  -4 
HLA-A,B,C  5 ×  10  -4  1.25 ×  10  -4  3.3 X 10  -4  1 ×  10  -4 
/32m  1 ×  10  -s  2.5 ×  10  -4  2.5 × 10  -4  1 ×  10  -4 
M°I  .... 
M-2  .... 
M-3  .... 
M-4  10  -5  10  -s  10  -4  10  -4 
M-5  10  -4  10  -4  10  -4  10  -4 
M-6  10  -4  10  -4  10  -4  10  -4 
M-7  10  -3  10  -s  10  -3  I0  -s 
M-8  10  -5  10  -5  10  -3  10  -s 
M-9  10  -3  10  -3  10  -3  10  -3 
M-10  10  -~  10  -2  10  -~  10  -~ 
M-14  10  -3  10  -s  10  -5  10  -5 
M-18  10  -4  10  -4  10  -~  10  -s 
M-19  10  -5  10  -5  10  -4  10  -4 
M-28  10  -5  10  -5  10  -5  10  -s 
M-32  10  -6  10  -6  10  -6  10  -6 
M-34  --  --  10  -5  01-5 
* Cells were cultured for 5 d with or without purified natural IFN-~, 100 
tested  for antigen expression  by anti-mouse Ig mixed hemadsorption or 
assays. Titer refers to dilution of antibody showing 50% rosetted cells. 
U/ml and 
protein A 
and HLA-A,B,C/fi2m expression and did not extend to the expression of a  wide 
range  of  other  cell  surface  antigens  or  to  other  phenotypic  traits  such  as 
pigmentation or morphology. These findings with melanoma ceils and melano- 
cytes indicate that Ia induction by IFN-3, is a  result of selective effects involving 
products  of Class  I/II  MHC  genes,  rather  than  the  result  of a  more  general 
change in the  differentiation program.  Similar studies by others  have  demon- 
strated that IFN-% but not IFN-oz or IFN-fi, enhances expression of Ia antigens 
on the surface of melanoma cells (1 1,  12). In their investigation of the mechanism 
of Ia regulation, Rosa et al. (12) showed that HLA-DR mRNA could be increased 
by  IFN-a,  IFN-/3,  and  IFN-3,.  However,  only  IFN-3,  was  found  to  produce  a 
corresponding increase in the cell surface expression of HLA-DR, and even in 
this  case  the  increase in  HLA-DR  mRNA  produced  by  IFN-3, did  not always 
correlate with surface expression of HLA-DR antigen. Thus, IFN-3, appears to 
regulate Ia antigen expression at the level of transcription, but posttranscriptional 
events are evidently necessary for expression of Ia at the cell surface. 
From  our  past  studies  of cell  surface  antigens of cultured  melanomas and 
melanocytes, we proposed that melanomas could be placed into three categories 
on  the  basis of cell surface  markers,  morphology, and pigmentation, and that 264  SPECIFICITY  OF  Ia  ANTIGEN  INDUCTION  BY  T-INTERFERON 
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FIGURE 7.  Ia phenotype of cultured cell lines before and after IFN-3, induction. Cells cultured 
without IFN-y, I'-I;  cells cultured with natural IFN-3, 200 U/ml for 3 d, I. Length of horizontal 
bars represent antibody titers: 0, <1150;  1+,  1/50-1/1,000;  2+, >1/1,000-1/10,000;  3+, 
> 1/10,000. Serological assay: anti-mouse Ig mixed hemadsorption assay with L243 antibody. 
melanomas in each of these categories mirrored the phenotypic characteristics 
of normal cells in early, intermediate, or late stages of melanocyte differentiation 
(9). Because Ia antigens are strongly expressed on melanoma cells corresponding 
to early or intermediate stages of melanocyte differentiation, with weak or no 
expression to well-differentiated melanoma cells,  we concluded that  Ia  ÷ mela- 
nomas correspond to progenitors at an earlier stage in the melanocyte lineage, HOUGHTON ET  AL.  265 
FIGURE 8.  Immunoprecipitation  of [sSS]methionine-labeled  extracts of human cell lines SK- 
MEL-113 (melanoma), HT-29 (colon cancer), and GCC-SV(C) (choriocarcinoma) with L243 
antibody. Immunoprecipitates  analyzed by SDS-PAGE. Noninduced  cells (CONTROL), cells 
induced with purified natural leukocyte  IFN-a 500 U/ml for 3 d (IFN-a) and cells induced 
with purified natural IFN-~, 200 U/ml for 3 d (IFN-7). a and/3 refer respectively, to heavy 
and light  chains of la molecules. 
whereas Ia- melanomas correspond to a  late stage.  Normal melanocytes from 
fetal, newborn, and adult skin do not express Ia antigens and, therefore, were 
thought to represent later stages in melanocyte differentiation. With the finding 
that melanocytes, similar to Ia- melanomas, can be induced to express Ia antigens 
by  IFN-q,,  it  appears  that  cells  in  the  melanocyte series  are  programmed  to 
express  Ia  antigens, perhaps  constitutively during early stages  of melanocyte 
differentiation, and as an inducible trait during later stages. This view depends, 
of course,  on  the  existence of an  Ia  + melanocyte precursor,  and attempts to 
isolate such cells are underway. An alternative way to interpret the existence of 
Ia  + melanomas is that constitutive Ia expression is a transformation-related trait 
that distinguishes malignant melanocytes from normal melanocytes (9,  10). The 
closest  precedent  for  this  in  experimental  systems would  be  the  anomalous 
expression of TL antigens in the TL  ÷ leukemias arising in TL- (nonexpressor) 
mouse strains (28).  Further studies of Ia expression during normal melanocyte 
differentiation and analysis of the structure and regulation of Class II genes in 
melanoma cells will be necessary to resolve these questions. 
It  has  been  a  surprise  to  find that  so  many different cell  types express  Ia 
normally or can be induced to express Ia antigens. In addition to Ia expression 
by cells involved in immune recognition, Ia antigens have been found on myeloid 
cells (29),  endothelial cells (30,  31),  fibroblasts (31),  erythroid cells (32),  and 
epithelial cell types (2, 4-8). Our investigation of cultured cell lines suggests that 
Ia antigen expression can be induced in many, if not most cell types. Similar to 
our findings with melanoma cell lines, nonmelanoma cell types fall into three 266  SPECIFICITY  OF  Ia  ANTIGEN  INDUCTION  BY  "r-INTERFERON 
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FIGURE 9.  Influence of IFN-~" on the expression of Ia and HLA-A,B,C antigens by three 
human cell types. Cells cultured in the absence of IFN-% O; cells cultured with purified natural 
IFN-~, 200 U/ml for 3 d, 0. Serological assay: anti-mouse Ig mixed hemadsorption assay with 
L243 antibody (anti-la) and W6]32 antibody (anti-HLA-A,B,C). 
general categories with regard to Ia expression and response to IFN-3, induction: 
constitutive,  inducible,  and  noninducible.  The  distinctive  characteristic  of the 
noninducible category is that  it includes tumor cell types that arise from germ 
cells (teratocarcinoma,  choriocarcinoma) or correspond to relatively early stages 
of  development  (neuroblastoma).  HLA-A,B,C  antigens  and  ~m,  which  are 
frequently expressed in  low or undetectable amounts in  this  group of tumors, 
can be induced by IFN-7. These findings indicate that the induction of Class I 
and Class II MHC products by IFN-y is independently regulated, and that Class 
I  antigens  may be  susceptible  to  induction  at  an  early  stage  of development, 
while Class II antigens may only be induced in more differentiated cell types. In 
addition, the Ia noninducible phenotype could have several explanations, ranging 
from  lack of transcription  of Class  II  genes to  transcription  of Class  II  genes 
without subsequent translation  or incorporation  of the Ia products into the cell 
surface. 
Ia  molecules have been found to participate  in  immune  reactions at several 
levels, from initial antigen  recognition to providing signals for immune regula- 
tion. The fact that many different cell types not belonging to the immune system 
express  Ia  constitutively or can  be induced  to express  Ia  by IFN-7  raises  the 
possibility that  most  somatic  cell  types can  function  as  antigen-presenting  or 
immune regulatory cells. Alternatively,  in addition to their role in the immune HOUGHTON  ET  AL.  267 
response,  Ia  antigens  could  function  in  a  broader,  nonimmune  context.  The 
appearance  of  Ia  antigens  during  defined  stages  in  erythroid  and  myeloid 
development (32, 33) suggests that Ia antigens have a role in differentiation that 
is not related to the immune response. 
Summary 
IFN-7 is known to induce expression of Ia antigens on a variety of cell types. 
In the present study, this activity of IFN-~ has been analyzed with a panel of 36 
melanoma cell lines, normal melanocytes, and 97 cell lines representing a range 
of other  differentiation  lineages.  55%  of the  melanoma  cell  lines  express  Ia 
antigens  in  a  constitutive  manner  without  IFN-~  induction.  Of the  16  Ia- 
melanoma lines,  13 could be induced to express Ia antigens by IFN-% whereas 
three were noninducible.  Melanocytes, which do not normally express Ia anti- 
gens, are converted to Ia expression by IFN-7.  Ia antigens  expressed constitu- 
tively or after IFN-7 induction were identified with antibodies detecting mono- 
morphic and  allomorphic  products of DR and  DC  loci.  IFN-7 appeared  to be 
unique in its ability to induce Ia expression on melanoma and melanocytes;  14 
other agents (including IFN-a and IFN-3) known to influence growth or differ- 
entiation  did not have Ia-inducing activity. Equally striking  is the restriction  of 
antigenic changes following IFN-7 induction to HLA-associated products; of the 
38  systems of cell  surface  antigens  examined,  only  HLA-A,B,C,  3~m,  and  Ia 
antigens  were affected.  A  variety of other  Ia- cell types were shown to be Ia- 
inducible by IFN-~,;  these included established lines of breast, colon, pancreas, 
bladder,  kidney,  ovary, and  brain  cancers,  and  cultures  of normal  fibroblasts, 
kidney epithelia,  and  epidermal  keratinocytes.  In  contrast,  three  tumor  types, 
teratocarcinoma,  choriocarcinoma,  and  neuroblastoma,  were not inducible for 
Ia  expression,  even  though  IFN-~,  could  induce  expression  of  HLA-A,B,C 
products.  The  broad  representation  of Ia antigens  on  most somatic cell  types 
expressed either constitutively or after IFN-q¢ can be viewed in an immunological 
context (antigen presentation/immune  regulatory signals) or could indicate that 
Ia products have functions other than those related to immune reactions. 
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